Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net income $ 1,299,135 $ 967,796  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 404,449 388,316  
Net loss on disposition or impairment 403,090 1,135,330  
Net franchise fees recognized upon termination of franchise agreements (306,594) (100,118)  
Provision for credit losses 85,216 0 $ 286,232
Stock-based compensation expense 280,000 293,941  
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable 460,366 1,462,554  
Prepaid expenses and other current assets (982,100) (2,017,426)  
Deferred franchise costs 194,015 173,864  
Deposits and other assets 23,278 15,914  
Accounts payable (678,729) (481,554)  
Accrued expenses 527,224 (2,989,008)  
Payroll liabilities (2,122,582) (1,075,561)  
Operating leases (805,391) (1,278,637)  
Deferred revenue (133,506) (245,129)  
Upfront regional developer fees (105,714) (73,230)  
Other liabilities (18,327) 122,294  
Net cash used in operating activities (1,476,170) (3,700,654)  
Cash flows from investing activities:      
Proceeds from sale of clinics 0 40,100  
Purchase of property and equipment (234,600) (331,505)  
Net cash used in investing activities (234,600) (291,405)  
Cash flows from financing activities:      
Payments of finance lease obligation 0 (4,354)  
Purchases of treasury stock under employee stock plans (56,528) (8,440)  
Purchases of treasury stock under employee stock plans (1,145,054) 0  
Proceeds from exercise of stock options 37,228 905,976  
Net cash (used in) provided by financing activities (1,164,354) 893,182  
Decrease in cash, cash equivalents and restricted cash (2,875,124) (3,098,877)  
Cash, cash equivalents and restricted cash, beginning of period 24,301,868 25,996,436 25,996,436
Cash, cash equivalents and restricted cash, end of period 21,426,744 22,897,559 24,301,868
Reconciliation of cash, cash equivalents and restricted cash:      
Cash and cash equivalents 20,684,014 21,918,175 23,601,810
Restricted cash 742,730 979,384  
Cash, cash equivalents and restricted cash, end of period 21,426,744 22,897,559 $ 24,301,868
Net cash paid for:      
Interest 12,500 12,500  
Income taxes, net of refunds $ 419 $ (57,000)